JUSTTHENEWS (Kevin Killough) - FDA approves updated COVID vaccines for 2026-27 season
All manufacturers said they'll have vaccines read for the 2026-27 immunization season.
All manufacturers said they'll have vaccines read for the 2026-27 immunization season.
On Thursday, a Food and Drug Administration panel will weigh the risks and benefits of a first-of-its-kind mRNA flu shot after initially refusing to consider it earlier this year. NewsNation's Anna Kooiman reports.
Eli Lilly can now seek regulatory approval and potentially launch the next-generation drug in 2027.
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.
PULSE POINTSWHAT HAPPENED: The U.S. Food and Drug Administration (FDA) has reversed a prior decision from last week and will review Moderna’s flu vaccine for possible approval.WHO WAS INVOLVED: Moderna, the FDA, Dr. Vinay Prasad, and FDA Commissioner Dr. Marty Makary.WHEN & WHERE: February 18, 2026, United States.IMPACT: The potential approval could make the vaccine […] The post FDA Reverses Rejection of Moderna MRNA Flu Vax, Will Now Review for Approval. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: The U.S. Food and Drug Administration (FDA) has reversed a prior decision from last week and will review Moderna’s flu vaccine for possible approval. WHO WAS INVOLVED: Moderna, the FDA, Dr. Vinay Prasad, and FDA Commissioner Dr. Marty Makary. WHEN & WHERE: February 18, 2026, United States. IMPACT: The potential approval could make the vaccine available for older adults in the upcoming flu season. IN FULL Moderna has announced that the U.S. Food and Drug Administration (FDA ) has decided to review its flu vaccine, reversing its previous rejection from last week. The initial rejection cited flaws in Moderna’s research design, but subsequent discussions led the FDA to agree to reconsider. Regulators are now…Open
Moderna announced the change Wednesday.
WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot. Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the new vaccine, made [...]
Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by White House.
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. Read more: https://www.newsnationnow.com/politics/ap-politics/ap-moderna-says-fda-refuses-its-application-for-new-mrna-flu-vaccine/ #health Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is your source for fact-based, unbiased news for all Americans.